Trevisan Giusto, Ruscio Maurizio, Cinco Marina, Nan Katiuscia, Forgione Patrizia, Di Meo Nicola, Tranchini Paolo, Nacca Massimo, Trincone Silvana, Rimoldi Sara Giordana, Giacomet Vania, Ricci Michela, Melandri Davide, Artioli Stefania, Monteforte Patrizia, Stinco Giuseppe, Bonin Serena
Department of Medical Sciences, University of Trieste, Trieste, Italy.
Azienda Sanitaria Universitaria Integrata Giuliano Isontina, and Friuli-Venezia Giulia Lyme Disease Regional Center, Trieste, Italy.
Front Pharmacol. 2023 Jun 16;14:1128142. doi: 10.3389/fphar.2023.1128142. eCollection 2023.
Lyme borreliosis (LB) is the most common vector-borne zoonotic inflammatory disease in the Northern Hemisphere. In Italy, the first case was diagnosed in 1985 in a woman in Liguria, while the second, in 1986 in Friuli-Venezia Giulia, documenting the infection in northern Italy. Both diagnoses were confirmed by serological assessment by an indirect immunofluorescence (IFI) technique. cultivation from both ticks and human lesions in Trieste (Friuli-Venezia Giulia) identified as the prevalent genospecies; nevertheless, , (), and (VS116 Group) were also detected, although less frequently. LB was also documented in other Italian regions: in Tuscany (1991), Trentino-Alto Adige (1995-1996), Emilia-Romagna (1998), Abruzzo (1998), and more recently, Lombardy. Nevertheless, data on LB in other Italian regions, especially in southern Italy and islands, are poor. The aim of this study is to document the spread of LB in Italy through the collection of data from LB patients in eight Italian hospitals located in different Italian regions. Diagnostic criteria for LB diagnosis are as follows: i) the presence of erythema migrans (EM) or ii) a clinical picture suggestive of LB, confirmed by serological tests and/or PCR positivity for detection. In addition, data also included the place of residence (town and region) and the place where patients became infected. During the observation period, 1,260 cases were gathered from the participating centers. Although different in extent from northern Italy to central/southern Italy, this study shows that LB is widespread throughout Italy.
莱姆病(LB)是北半球最常见的媒介传播人畜共患炎症性疾病。在意大利,1985年在利古里亚的一名女性中诊断出首例病例,1986年在弗留利-威尼斯朱利亚诊断出第二例病例,这证明了意大利北部存在该感染。这两例诊断均通过间接免疫荧光(IFI)技术的血清学评估得到证实。在的里雅斯特(弗留利-威尼斯朱利亚)从蜱虫和人类病变中培养出被确定为流行的基因种;然而, 、 ( )和 (VS116组)也被检测到,尽管频率较低。莱姆病在意大利其他地区也有记录:托斯卡纳(1991年)、特伦蒂诺-上阿迪杰(1995 - 1996年)、艾米利亚-罗马涅(1998年)、阿布鲁佐(1998年),以及最近的伦巴第。然而,关于意大利其他地区,特别是意大利南部和岛屿的莱姆病数据很少。本研究的目的是通过收集位于意大利不同地区的八家意大利医院的莱姆病患者数据,记录莱姆病在意大利的传播情况。莱姆病诊断的标准如下:i)存在游走性红斑(EM)或ii)血清学检测和/或检测的PCR阳性确认的提示莱姆病的临床表现。此外,数据还包括居住地点(城镇和地区)以及患者感染的地点。在观察期内,从参与中心收集了1260例病例。尽管从意大利北部到中/南部在范围上有所不同,但这项研究表明莱姆病在意大利广泛传播。